Shares of Delcath Systems Inc. (NASDAQ:DCTH) saw unusually-high trading volume on Friday . Approximately 195,932 shares were traded during mid-day trading, an increase of 194% from the previous session’s volume of 66,575 shares.The stock last traded at $4.08 and had previously closed at $3.92.

The firm has a 50-day moving average price of $3.95 and a 200-day moving average price of $4.72. The stock’s market capitalization is $6.40 million.

Delcath Systems (NASDAQ:DCTH) last announced its quarterly earnings data on Wednesday, May 4th. The medical device company reported ($0.08) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.19) by $0.11. Equities research analysts anticipate that Delcath Systems Inc. will post ($7.84) EPS for the current year.

Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.